COVID-19 related immune hemolysis and thrombocytopenia

J Med Virol. 2021 Feb;93(2):1164-1170. doi: 10.1002/jmv.26402. Epub 2020 Aug 16.

Abstract

The current pandemic due to coronavirus disease 2019 (COVID-19) has posed an unprecedented challenge for the medical communities, various countries worldwide, and their citizens. Severe acute respiratory syndrome coronavirus 2 has been studied for its various pathophysiological pathways and mechanisms through which it causes COVID-19. In this study, we discussed the immunological impact of COVID-19 on the hematological system, platelets, and red blood cells.

Keywords: coronavirus; hemolysis; immunity.

Publication types

  • Review

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Blood Platelets / pathology
  • COVID-19 / blood
  • COVID-19 / complications*
  • COVID-19 / immunology*
  • Erythrocytes / pathology
  • Female
  • Hemolysis / immunology*
  • Humans
  • Male
  • Middle Aged
  • Thrombocytopenia / virology*
  • Young Adult